Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.17
Delayed Data
As of 1:49pm ET
 -0.01 / -0.46%
Today’s Change
1.53
Today|||52-Week Range
4.20
+17.93%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close2.18
Today’s open2.16
Day’s range2.14 - 2.19
Volume49,593
Average volume (3 months)203,475
Market cap$204.1M
Dividend yield--
Data as of 1:49pm ET, 05/04/2015

Growth & Valuation

Earnings growth (last year)-6.67%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.68%
P/E ratioNM
Price/Sales11.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd+0.30+2.48%
CYTRCytRx Corp+0.98+26.49%
ENZYEnzymotec Ltd+0.07+0.79%
PSTIPluristem Therapeuti...-0.03-1.10%
Data as of 2:04pm ET, 05/04/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$15.2M
Annual profit (last year)-$29.9M
Net profit margin-197.51%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Haifa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers